GlassScriptPhysician profile
Rosalyn Velasquez
NPI 1639715667
$1,047.54
in general payments reported to CMS, 2019-2025
10 companies · $70.20 in 2025
The $70.20 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $395 · 2023: $177 · 2024: $94.26 · 2025: $70.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $661.67 | 2021-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.14 | 2021-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $78.39 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $60.07 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $40.68 | 2025 | General - Ep, Farapulse |
| Atricure, INC. | $29.52 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $25.04 | 2022-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $24.46 | 2024 | Wainua |
| Recor Medical INC | $23.80 | 2024 | Paradise Renal Denervation System |
| Teleflex LLC | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosalyn Velasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.